NBTX · Nanobiotix ADR
United States · RS rating 54 · As of 2026-11-03
| Price | 28.56 USD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 88 / 23 / 79 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 32 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +48.1% |
| Market cap (USD) | $1.6B |